Age Of Onset Of Childhood Onset Asthma
Introduction
Asthma is a complex, chronic inflammatory disease of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. It is a leading chronic childhood disease, with prevalence rates reaching historically high levels and continuing to increase in many countries worldwide . For instance, in some cohorts, no single nucleotide polymorphisms (SNPs) reached genome-wide significance, nor did replication SNPs achieve significance after stringent multiple testing corrections, suggesting an inability to detect all true genetic associations. [1] Such power limitations are especially pronounced in populations that are historically under-represented in genetic research, potentially leading to an incomplete understanding of genetic influences. [1] Furthermore, the selection of study participants, such as recruiting asthmatic children primarily from pediatric allergy clinics, can introduce cohort bias by over-representing allergic asthma phenotypes and limiting the generalizability of findings to the full spectrum of childhood asthma. [1]
Replication of initial GWAS findings is crucial for validating associations and distinguishing true signals from false positives, yet this process is often complicated by differences in study design, population demographics, and diagnostic criteria. [1] Some studies lacked comprehensive age-of-onset data for a substantial proportion of cases, precluding its inclusion in the primary analysis and potentially obscuring genetic variants specifically influencing the timing of asthma onset. [2] While some research utilized robust designs, such as case-parent trios, to mitigate population stratification, other technical variables, like array batch effects, could introduce confounding if not carefully managed. [2]
Phenotypic Heterogeneity and Generalizability
A significant challenge in studying the age of onset of childhood asthma lies in the heterogeneity of the phenotype itself and the generalizability of findings across diverse populations. The definition of "childhood-onset asthma" can vary between studies, with different age cutoffs (e.g., younger than 18 years versus younger than 16 years), which can introduce inconsistencies and complicate the synthesis of results. [1] This variability in phenotypic definition contributes to genetic heterogeneity, making it more difficult to identify universally applicable genetic markers. [3] Diagnostic criteria for asthma also differ, with some studies relying on physician diagnoses and symptom questionnaires without objective measures like bronchial hyper-responsiveness, potentially leading to some degree of misclassification or inclusion of non-asthma respiratory conditions. [1] The reliance on self-reported information, sometimes gathered through non-identical survey questions, further adds to the imprecision of the asthma phenotype. [2]
The generalizability of genetic findings is heavily influenced by the ancestral composition of the study cohorts. Many large-scale GWAS have predominantly involved populations of European descent, which limits the applicability of their findings to other ancestral groups. [1] Genetic variants that are common or have a significant effect in one population may be rare or have different effects in another, as evidenced by loci showing nominal association in white populations but stronger signals in Mexican children. [1] This highlights the necessity of conducting genetic studies in diverse populations, particularly those with significant Native American or admixed ancestries, to fully capture the genetic landscape of childhood-onset asthma and ensure findings are broadly relevant. [1]
Environmental Confounders and Remaining Knowledge Gaps
The etiology of childhood-onset asthma is complex, involving intricate interactions between genetic predispositions and environmental exposures, which are often challenging to fully account for in genetic studies. While some research has begun to explore gene-environment interactions, such as the modifying effects of air pollution or environmental tobacco smoke on genetic associations, a comprehensive understanding of these complex interplay mechanisms remains largely elusive. [1] The absence of detailed and consistently collected environmental exposure data across all study cohorts limits the ability to identify specific gene-environment interactions that could critically influence the age of asthma onset and disease severity.
Despite significant advances in identifying genetic susceptibility loci, substantial knowledge gaps persist regarding the complete genetic architecture of childhood-onset asthma. Asthma is increasingly recognized as a heterogeneous condition, with distinct genetic influences potentially contributing to different phenotypes and age-of-onset patterns; for instance, later-onset asthma may show stronger associations with the MHC region compared to childhood-onset cases. [3] This inherent heterogeneity, combined with the observation that genetics alone cannot easily predict an individual's risk of asthma, underscores the need for continued research utilizing integrative approaches to unravel the complex biological pathways and identify the full spectrum of genetic and non-genetic factors driving childhood-onset asthma. [3]
Variants
Genetic variations play a significant role in an individual's susceptibility to childhood-onset asthma, influencing immune responses and airway inflammation. The GSDMB gene, located in a critical region on chromosome 17q21, is strongly associated with the risk of childhood asthma. Variants within this locus, such as rs4795399, are thought to impact immune cell function and epithelial integrity, contributing to the development of early-onset disease. [1] Nearby, the IL18R1 and IL1RL1 genes on chromosome 2q12 are also significantly linked to asthma susceptibility. Specifically, the rs10197862 variant in IL1RL1 has been shown to increase asthma risk and influence eosinophil levels, key indicators of allergic inflammation prevalent in childhood asthma. [2] These genetic associations underscore pathways involved in the initial immune development and allergic sensitization, which are particularly relevant for how early asthma begins.
Several other genes involved in immune signaling and inflammation are implicated in asthma. The TSLP gene encodes Thymic Stromal Lymphopoietin, a cytokine crucial for initiating type 2 helper T-cell (Th2) inflammation, a hallmark of allergic asthma. The rs1837253 variant within TSLP has shown a suggestive association with severe asthma, indicating its potential impact on disease severity and immune regulation. [3] The IL5 gene is another key Th2 cytokine, essential for the growth and activation of eosinophils, immune cells frequently elevated in asthma. While specific mechanisms of rs2078386 are still being explored, variants in the IL5 region can contribute to the allergic inflammatory cascade, influencing the development and persistence of childhood asthma. [4] Similarly, STAT6 is a critical signal transducer and activator of transcription involved in Th2 cell differentiation and IgE production, with its variants like rs3122929 impacting the immune response and total serum IgE levels, a common feature in childhood asthma. [3]
Immune regulation and cellular processes are also influenced by other associated genes. The RORA gene, encoding Retinoic acid-related orphan receptor alpha, is involved in regulating circadian rhythms and immune cell differentiation, including Th2 cells, which are central to asthma pathogenesis. Variants like rs10519068, or other variants such as rs11071559 within RORA, have been associated with asthma, potentially influencing inflammatory pathways relevant to childhood onset. [3] The CLEC16A gene, a C-type lectin domain family member, plays a role in immune regulation and autoimmune diseases, with variants like rs12935657 potentially affecting immune cell development or function. Its involvement in asthma, particularly childhood onset, may include modulating immune tolerance or susceptibility to environmental triggers, highlighting the complex genetic architecture of common diseases. [3] Furthermore, the TLR1 gene, encoding Toll-like receptor 1, is part of the innate immune system, recognizing microbial components and initiating inflammatory responses. The rs5743618 variant in TLR1 could alter innate immune signaling, potentially influencing susceptibility to respiratory infections that often trigger or exacerbate childhood asthma. [4]
Finally, less characterized genetic regions may also contribute to asthma risk. The region encompassing EMSY and LINC02757 (Long Intergenic Non-Coding RNA 02757), with variants such as rs7936323, suggests a role in gene regulation and cellular processes that could indirectly impact asthma susceptibility. While EMSY is primarily known for DNA repair, its interaction with LINC02757 might influence immune cell function or epithelial barrier integrity, contributing to the complex etiology of childhood asthma. [3] The D2HGDH gene, which encodes D-2-hydroxyglutarate dehydrogenase, is involved in cellular metabolism. The rs34290285 variant might affect metabolic pathways that are increasingly recognized for their interplay with immune responses, potentially modulating the risk or severity of childhood-onset asthma. [4] Such genetic discoveries, often emerging from large-scale genome-wide association studies, continue to deepen our understanding of this heterogeneous condition.
Key Variants
Evolution of Asthma Understanding and Genetic Insights
Asthma has long been recognized as a significant chronic condition, particularly impacting children. Historically, its understanding has evolved from early clinical observations of airway obstruction and inflammation to a more nuanced view encompassing complex genetic and environmental interactions. [1] The disease is characterized by inflammation and bronchoconstriction in the airways, leading to airflow obstruction, though the precise mechanisms driving its development remain a subject of ongoing research. [1] Twin studies have been instrumental in establishing a strong genetic component to asthma, especially in its childhood-onset form, with heritability estimates suggesting that 48-79% of asthma risk is attributable to genetic factors. [1]
The advent of genome-wide association studies (GWAS) marked a significant leap in identifying specific genetic loci associated with childhood asthma. Landmark studies have identified multiple genetic variants that contribute to disease risk, such as the ORMDL3 locus on chromosome 17q21, which has been strongly and reproducibly associated with childhood-onset asthma. [5] This locus, specifically rs2305480 within the ORMDL3/GSDMB region, has been shown to be particularly specific to childhood-onset disease. [3] Further research has implicated other genes, like PDE4D and DENND1B, and identified additional susceptibility regions, including chromosome 9q21.31 (containing TLE4), suggesting that asthma is a genetically heterogeneous condition where later-onset cases may be influenced more by the MHC region compared to childhood-onset cases. [1] These genetic insights point towards pathways involving communication between epithelial damage and the adaptive immune system, leading to airway inflammation. [3]
Global Burden and Changing Epidemiological Landscape
The global epidemiological landscape of asthma reveals a significant and increasing public health burden. Prevalence rates for asthma have reached historically high levels, with the United States reporting rates as high as 8.9%. [1] This upward trend is not isolated to the U.S. but continues to be observed in many countries worldwide, signifying a secular trend of increasing asthma prevalence. [1] Childhood-onset asthma, in particular, contributes substantially to this global burden due to its chronic and often relapsing course, impacting the quality of life for millions of children and their families. [3] The persistent increase in prevalence highlights the ongoing need for research into the complex interplay of genetic and environmental factors that drive disease development and progression.
Demographic Influences on Childhood Asthma
Demographic factors play a crucial role in the prevalence and presentation of childhood asthma. Childhood-onset asthma is typically defined as the presence of the disease in individuals younger than 16 years of age, distinguishing it from later-onset forms that develop at 16 years or older. [3] Across various studies, a consistent demographic pattern observed in childhood asthma cases is a male predominance; for instance, cohorts of children with asthma have shown males comprising 57% to 58.7% of cases, compared to slightly lower percentages in control groups. [6] The mean age of children with asthma in these studies typically ranges from 7.5 to 9.0 years at the time of assessment or enrollment. [6]
Ancestry and socioeconomic status also contribute to the epidemiological patterns of childhood asthma. Genetic studies have increasingly included diverse populations, such as Mexican children, African American children, and individuals of European descent from various countries, to capture a broader spectrum of genetic and environmental influences. [1] Research suggests that specific genetic loci, like chromosome 9q21.31, may underlie ethnic differences in childhood asthma susceptibility, underscoring the importance of population-specific genetic investigations. [1] Environmental factors, such as exposure to parental smoking during childhood and residential ambient ozone levels, have also been investigated as potential risk factors, with studies noting varying prevalences of these exposures within different cohorts. [1]
Genetic Heterogeneity and Diagnostic Utility
Childhood-onset asthma represents a distinct phenotypic entity compared to later-onset asthma, primarily due to differing underlying genetic influences. [3] Studies typically define childhood-onset asthma as a diagnosis made before 16 years of age. [3] This distinction is crucial for accurate diagnosis and classification, as research indicates that later-onset asthma is more strongly influenced by the MHC region, whereas childhood-onset asthma exhibits a robust and specific association with the chromosome 17q locus. [3]
The identification of specific genetic susceptibility loci, such as those on chromosome 17q21 (which includes ORMDL3) and chromosome 9q21.31 (including TLE4), offers valuable insights for the diagnostic process of childhood-onset asthma. [3] These genetic markers can assist in differentiating childhood-onset asthma from other respiratory conditions and contribute to a more precise diagnosis, particularly in diverse populations where these associations have been identified. [1] Furthermore, understanding the involvement of genetic variants, such as those in DENND1B, in influencing asthma risk in children underscores the complex genetic landscape of this disease. [7]
Prognostic Indicators and Risk Stratification
The age of asthma onset, particularly during childhood, serves as a significant prognostic indicator, influencing predictions regarding disease progression and long-term health outcomes. The strong association of the chromosome 17q21 locus with childhood-onset asthma and the impact of its variants on early-onset disease suggest that specific genetic profiles identified at diagnosis could aid in stratifying individuals based on their anticipated disease course. [3] For example, the presence of certain genetic variants might indicate a higher likelihood of persistent asthma or a particular response to environmental factors, such as smoking exposure, in those with early-onset asthma. [3]
Risk stratification in childhood-onset asthma can be refined by integrating genetic findings with observed clinical characteristics. Although individual genetic risk assessment for asthma using single nucleotide polymorphisms (SNPs) currently demonstrates moderate sensitivity and specificity, the identification of loci like 9q21.31 as a susceptibility locus for childhood asthma contributes to identifying individuals at potentially higher genetic risk. [1] Additionally, population-specific data, such as the high prevalence of atopy (91.7%) and mild asthma (72.3%) among Mexican children with asthma in one study, provides a clinical context that can be combined with genetic data for more comprehensive risk assessment. [1]
Personalized Treatment and Prevention Strategies
A deeper understanding of the distinct genetic architecture of childhood-onset asthma, particularly the strong and specific influence of the chromosome 17q locus, opens pathways for developing personalized medicine approaches. The recognition that later-onset asthma cases are influenced differently by the MHC region compared to childhood-onset cases suggests that treatment selection could eventually be tailored based on the patient's age of onset and their specific genetic profile. [3] This genetic insight holds the potential to guide the development of therapies that target specific molecular pathways relevant to childhood-onset disease, leading to more effective and individualized interventions.
Prevention strategies for childhood-onset asthma could also significantly benefit from targeted genetic insights. The identification of susceptibility loci for childhood asthma, such as 9q21.31, and variants regulating ORMDL3 expression, provides specific targets for future research aimed at primary prevention. [1] While current genetic risk assessment for individual asthma risk is not yet highly predictive, these findings contribute to an expanding understanding of the complex multigenic etiology of childhood asthma, which is essential for developing comprehensive prevention programs that can integrate both genetic predispositions and environmental risk factors. [3]
Epidemiological Landscape and Demographic Patterns of Childhood Asthma
Asthma is recognized as a leading chronic childhood disease, with studies observing historically high prevalence rates, such as 8.9% in the United States, and a continued increase in many countries globally. [1] Epidemiological investigations have highlighted notable demographic patterns in childhood asthma. For instance, studies on Mexican children with asthma reported a higher proportion of males (58.7%) compared to females (41.3%), with an average age at enrollment around 9.0 years. [1] Similar observations were made in cohorts of white and African American children, where cases often had a higher male predominance and comparable mean ages to controls, albeit with some variation across specific cohorts. [6] These population-level findings underscore the significant public health burden of childhood asthma and suggest potential sex-based differences in susceptibility or diagnosis patterns.
Beyond basic demographics, population studies have explored various epidemiological associations and environmental correlates influencing childhood asthma. In Mexican children, a substantial majority (91.7%) of those with asthma were found to be atopic, indicating a strong link between allergic sensitization and disease presentation. [1] While maternal smoking during pregnancy was reported by a small percentage, current parental smoking was present in about half of the families, pointing to household environmental exposures as a population-level factor. [1] Furthermore, residential ambient ozone exposure was also characterized, suggesting environmental air quality as another potential correlate for childhood asthma within urban populations. [1] Such epidemiological data, including prevalence of respiratory morbidity in communities, are crucial for understanding the multifactorial etiology of childhood asthma and for informing public health interventions. [8]
Genetic Susceptibility and Cross-Population Variability
Population studies have increasingly focused on identifying genetic susceptibility loci for childhood asthma across diverse ethnic and geographic groups, recognizing that genetic architectures can vary significantly. For instance, while many genetic studies historically concentrated on populations of European descent, research has expanded to include underrepresented groups, such as Hispanic populations. [1] A genome-wide association study (GWAS) on Mexican children with asthma, utilizing a case-parent trio design, aimed to identify novel susceptibility genes, with findings later examined in an independent replication cohort of Mexican ethnicity. [1] This approach is critical in admixed populations to protect against bias due to population stratification, a common challenge in genetic epidemiology.
Cross-population comparisons have revealed insights into population-specific effects and the generalizability of genetic findings. Studies have explicitly recruited cohorts of varying ancestries, including North American children of European ancestry and African American children, allowing for direct comparisons of genetic associations across these groups. [7] Similarly, different cohorts within a single study have included white children of Northern European descent and African American children, using ancestry-informative markers to ensure minimal population stratification and robust association testing. [6] The inclusion of samples from Europe, Canada, Australia, and the U.S. in large consortium-based GWAS further highlights the global effort to understand genetic contributions to childhood asthma, while also necessitating careful consideration of population substructure through methods like multidimensional scaling analysis to prevent spurious associations. [3]
Methodological Approaches in Large-Scale Genetic Studies
Large-scale population studies investigating the age of onset of childhood asthma employ rigorous methodologies to ensure the validity and generalizability of their findings. Common study designs include genome-wide association studies (GWAS) utilizing both case-control and case-parent trio designs, with some studies integrating data from over 10,000 case subjects and 16,000 controls across multiple international cohorts and surveys. [3] For instance, in studies involving Mexican children, the case-parent trio design was specifically chosen to mitigate bias from population stratification in an admixed population, with subjects diagnosed before age 18 defined as having childhood asthma. [1] Similarly, other GWAS have defined childhood-onset asthma as diagnosis before 16 years of age, ensuring consistency in phenotype definition across diverse study populations. [3] The British 1958 birth cohort study, for example, has provided longitudinal insights into asthma onset and relapse, demonstrating the value of long-term population tracking. [9]
Methodological rigor extends to comprehensive quality control and statistical analyses to ensure robust results. Studies routinely perform extensive SNP and subject-level quality control, including checks for missingness, minor allele frequency, Hardy-Weinberg equilibrium, Mendelian errors, and subject relatedness. [1] Ancestry checks are crucial, often involving ancestry-informative markers or comparison with HapMap populations, to detect and account for population stratification, which could otherwise lead to spurious associations. [6] While large sample sizes from consortium efforts enhance statistical power, some studies acknowledge limitations, such as not achieving genome-wide significance in smaller cohorts or the unavailability of precise age-of-onset information for a substantial portion of cases, which can restrict certain analyses. [1] The generalizability of findings is frequently assessed through replication attempts in independent populations, underscoring a commitment to validating identified associations. [6]
Epithelial Sensing and Innate Immune Activation
The initiation of childhood-onset asthma involves complex interactions beginning with the airway epithelium. IL33, an interleukin primarily detected in airway epithelial cells, plays a crucial role by activating nuclear factor κB (NF-κB) and mitogen-activated protein (MAP) kinases. [3] This activation drives the production of Th2-associated cytokines, such as interleukin-4, interleukin-5, and interleukin-13, which are central to the inflammatory response characteristic of asthma. [3] The IL18R1 gene also contributes to this pathway, potentially modifying the inflammatory response following epithelial damage. These mechanisms highlight how the initial sensing of environmental cues by epithelial cells translates into downstream inflammatory cascades, establishing a critical communication link between epithelial damage and the adaptive immune system.
Adaptive Immune Modulation and T-cell Homeostasis
Beyond initial inflammatory signals, the regulation of adaptive immune cells is vital in determining asthma's course. The interleukin-2 receptor beta chain, encoded by IL2RB, acts as a signal-transduction element that is also part of the interleukin-15 receptor. [3] Interleukin-2 itself is fundamental for the survival and proliferation of regulatory T cells, and it influences the differentiation and homeostasis of various effector T-cell subgroups, including Th1, Th2, Th17, and memory CD8+ T cells. [3] Concurrently, SMAD3 is implicated in regulating homeostatic and healing pathways within the airways. Together, these regulatory mechanisms are crucial for balancing immune responses, potentially down-regulating excessive airway inflammation and remodeling, and maintaining immune tolerance in the context of childhood asthma.
Lipid Metabolism and Airway Inflammatory Regulation
A significant genetic susceptibility locus for childhood-onset asthma is found on chromosome 17q21, involving the ORMDL3 and GSDMB genes. [3] Genetic variants in this region regulate the expression of ORMDL3, which has been identified as a determinant of susceptibility to childhood asthma. [5] Functional studies in yeast involving the homologous ORM gene indicate that its dysregulation leads to alterations in sphingolipid metabolism. [3] This suggests that similar metabolic pathways in humans, particularly those involving sphingolipids, could modulate airway inflammation and remodeling, presenting a potential mechanism for disease development and a target for therapeutic intervention.
Cyclic Nucleotide Signaling and Bronchial Reactivity
Intracellular signaling pathways, particularly those involving cyclic nucleotides, are critical regulators of airway function. The PDE4D gene, encoding phosphodiesterase 4D, has been identified as an asthma-susceptibility gene. [6] PDE4D is a cAMP-specific phosphodiesterase, meaning it hydrolyzes cyclic AMP (cAMP), a key second messenger involved in various cellular processes. By regulating intracellular cAMP levels, PDE4D influences signaling cascades that control airway smooth muscle tone, inflammatory cell activation, and mucus secretion. Dysregulation of PDE4D activity can therefore alter these critical cellular functions, contributing to features like bronchoconstriction and inflammation that are characteristic of childhood asthma.
Genetic Determinants and Pathway Crosstalk
Childhood asthma is a complex condition with a multigenic etiology, indicating that multiple genetic risk factors interact to influence its development. [1] For instance, chromosome 9q21.31, encompassing genes such as TLE4, has been identified as a novel candidate susceptibility locus for childhood asthma. [1] Additionally, variants in DENND1B are associated with asthma in children. [7] These distinct genetic loci, affecting diverse pathways from epithelial defense and immune regulation to lipid metabolism and intracellular signaling, demonstrate extensive pathway crosstalk and network interactions. The integration of these genetically influenced mechanisms ultimately leads to the emergent properties of airway inflammation and hyperresponsiveness observed in childhood-onset asthma.
Frequently Asked Questions About Age Of Onset Of Childhood Onset Asthma
These questions address the most important and specific aspects of age of onset of childhood onset asthma based on current genetic research.
1. My parents had asthma. Will my child definitely get it young?
No, not definitely. While asthma has a strong genetic component, meaning certain genetic variations can increase your child's susceptibility, it's a complex disease. Its development is influenced by both inherited genetic predispositions and various environmental factors, so a family history increases risk but doesn't guarantee early onset.
2. Why did I get asthma as a kid, but my sibling didn't?
Even within families, genetic inheritance can differ, leading to variations in risk. Specific genetic regions, such as the chromosome 17q21 locus which includes genes like ORMDL3, play a significant role in childhood-onset asthma. Your unique combination of inherited genetic variants and environmental exposures likely contributed to your asthma, while your sibling may have received different protective or risk-modulating variants.
3. Is asthma diagnosed later in childhood different from earlier cases?
Yes, research suggests there can be genetic differences. While childhood-onset asthma often links to specific regions like chromosome 17q21, later-onset cases may be more influenced by other areas, such as the Major Histocompatibility Complex (MHC) region. This highlights that asthma isn't a single disease but a group of conditions with varying underlying genetic causes.
4. Does my family's ethnic background affect my child's asthma risk?
Yes, ethnic background can play a role due to differences in genetic predispositions and environmental exposures common within certain populations. For example, specific genetic regions on chromosome 9q21.31 have been identified as susceptibility loci for asthma particularly in Mexican children. This underscores the importance of diverse research to understand varied risk factors globally.
5. Can I do anything to prevent my child from getting asthma early?
While genetic factors predispose some children, environmental factors also play a crucial role. Reducing exposure to common asthma triggers, such as allergens and pollutants, can be important in managing risk. Ongoing research aims to improve early detection and develop more effective preventive measures by understanding both genetic and environmental contributions.
6. Why is knowing when my child got asthma so important for doctors?
Knowing the age of onset helps doctors tailor treatment strategies and anticipate the disease's progression and potential long-term outcomes. It can also hint at underlying genetic differences, as specific genetic factors are more strongly associated with childhood-onset asthma. This information is crucial for personalized patient care.
7. Why do some children with asthma need stronger medicine?
The severity of asthma in children can vary greatly, from mild to severe, and this often dictates the intensity of treatment. These differences in severity are influenced by both an individual's genetic makeup and their specific environmental exposures. For example, persistent asthma, often linked to roles of genetic factors in immune regulation, may require daily inhaled glucocorticoid therapy, while milder cases might not.
8. Can a DNA test tell me if my baby will get asthma?
While genetic studies have identified many genes linked to asthma susceptibility, like ORMDL3 or PDE4D, genetic factors alone cannot precisely predict individual asthma risk. Asthma is complex, involving many genes and environmental interactions. However, identifying these genetic factors enhances our understanding of disease mechanisms, which could eventually lead to better risk assessment and targeted interventions.
9. Does living in a specific environment make my child more likely to get asthma?
Yes, environmental exposures are critical in the development of childhood asthma, interacting with an individual's genetic predisposition. Factors like air pollution, allergens, and other environmental triggers can significantly influence who develops the disease and how severely. Understanding these interactions is key to both prevention and management.
10. Is it just bad luck if my child develops asthma early?
It's more complex than just "bad luck." Childhood asthma is a complex disease resulting from intricate interactions between an individual's inherited genetic predispositions and their unique environmental exposures. While you can't control all factors, understanding these genetic and environmental influences helps in diagnosis, management, and ongoing research for better prevention and treatment strategies.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Hancock DB, et al. "Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in mexican children." PLoS Genet, vol. 5, no. 8, 2009, p. e1000623.
[2] Ferreira MA, et al. Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia. Eur J Hum Genet. 2011 May;19(5):565-71.
[3] Moffatt MF, et al. "A large-scale, consortium-based genomewide association study of asthma." N Engl J Med, vol. 363, no. 13, 2010, pp. 1213-21.
[4] Li, X. et al. "Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions." J Allergy Clin Immunol, vol. 125, no. 2, 2010, pp. 328–335.e11.
[5] Moffatt MF, et al. "Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma." Nature, vol. 448, no. 7152, 2007, pp. 470-3.
[6] Himes BE, et al. "Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene." Am J Hum Genet, vol. 84, no. 5, 2009, pp. 581-93.
[7] Sleiman PM, et al. "Variants of DENND1B associated with asthma in children." N Engl J Med, vol. 361, no. 26, 2009, pp. 2517-26.
[8] Peters, J. M., et al. "A study of twelve Southern California communities with differing levels and types of air pollution. I. Prevalence of respiratory morbidity." American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 3, 1999, pp. 760-767.
[9] Strachan, D. P. "Asthma onset and relapse in adult life: The British 1958 birth cohort study." Annals of Allergy, Asthma & Immunology, vol. 98, no. 4, 2007, pp. 337-343.